Rapalogix Health, Inc. — Form D/A

Rapalogix Health, Inc. of CARLSBAD, CA, a company, filed a Form D amendment with the SEC on 2025-06-04. The offering totals $13.5M, of which $9.1M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-06-04
• Form: D/A
• Accession: 0002008372-25-000002
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $13.5M
• Amount sold: $9.1M
• Remaining: $4.4M
• Investors: 24
• Date of first sale: 2023-12-22
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-502595

Issuer

• Name: Rapalogix Health, Inc.
• CIK: 0002008372
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: 3129 TIGER RUN COURT SUITE 207, CARLSBAD, CA, 92010
• Phone: (760) 707-2412

Officers, directors & promoters (17)

Other filings by this issuer (2)

More

• CIK 2008372 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search